Azienda Ospedaliera Universitaria Careggi, Radiotherapy Unit, Oncology Department, University of Florence, Florence, Italy.
Azienda Ospedaliera Universitaria Careggi, Radiotherapy Unit, Oncology Department, University of Florence, Florence, Italy.
Crit Rev Oncol Hematol. 2021 Jan;157:103184. doi: 10.1016/j.critrevonc.2020.103184. Epub 2020 Nov 28.
In case of circumscribed recurrent glioblastoma (rec-GBM), a second surgery (Re-S) and reirradiation (Re-RT) are local strategies to consider. The aim is to provide an algorithm to use in the daily clinical practice. The first step is to consider the life expectancy in order to establish whether the patient should be a candidate for active treatment. In case of a relatively good life expectancy (>3 months) and a confirmed circumscribed disease(i.e. without multiple lesions that are in different lobes/hemispheres), the next step is the assessment of the prognostic factors for local treatments. Based on the existing prognostic score systems, patients who should be excluded from local treatments may be identified; based on the validated prognostic factors, one or the other local treatment may be preferred. The last point is the estimation of expected toxicity, considering patient-related, tumor-related and treatment-related factors impacting on side effects. Lastly, patients with very good prognostic factors may be considered for receiving a combined treatment.
对于局限性复发性胶质母细胞瘤(rec-GBM),可考虑进行第二次手术(Re-S)和再放疗(Re-RT),这是两种局部治疗策略。本研究旨在提供一种可用于日常临床实践的算法。第一步是考虑患者的预期寿命,以确定其是否适合接受积极治疗。如果预期寿命相对较长(>3 个月),且疾病局限(即无位于不同脑叶/半球的多发病灶),则下一步是评估局部治疗的预后因素。基于现有的预后评分系统,可以识别出不应接受局部治疗的患者;根据已验证的预后因素,可以选择一种或另一种局部治疗方法。最后一点是评估预期毒性,考虑影响副作用的与患者相关、与肿瘤相关和与治疗相关的因素。最后,对于预后良好的患者,可以考虑采用联合治疗。